WHO ICTRP trial
A prospective, multicenter, parallel, single-blind, randomized, pivotal study to…
KCT0005960 · Clinical Research Information Service (CRIS) · Recruiting
Key facts
| Trial ID | KCT0005960 |
|---|---|
| Public title | A prospective, multicenter, parallel, single-blind, randomized, pivotal study to evaluate the safety and efficacy of the everolimus eluting bioresorbable stent ‘BRSTM’ compared to 'XIENCETM' stent in patients with de novo coronary artery lesions. |
| Scientific title | A prospective, multicenter, parallel, single-blind, randomized, pivotal study to evaluate the safety and efficacy of the everolimus eluting bioresorbable stent ‘BRSTM’ compared to 'XIENCETM' stent in patients with de novo coronary artery lesions. |
| Primary sponsor | Dotter |
| Secondary sponsors | Dotter |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Recruiting |
| Study type | Interventional Study |
| Phase | Not applicable |
| Countries | Korea, Republic of |
| Conditions | Not Applicable |
| Interventions | Medical Device : This non-inferiority trial randomized patients are experiencing a 1:1 ratio of the BRSTM or SierraTM. A total of 128 patients from multi-centers are randomized to either the BRSTM group (n = 64) or the XIENCE SierraTM group… |
| Registration date | Mar 5, 2021 |
| Target size | 128 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: